id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-4853-0003,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar Applicant,Notice,General Notice,2018-09-12T04:00:00Z,2018,9,2018-09-12T04:00:00Z,,2018-09-12T13:44:59Z,2018-19811,0,0,09000064836df572